http://www.acc.org/Feed?clinicalTopicID=277d44d1-8fe9-4754-b6e3-a30df1945db7 Clinical Topic Feed: Statins en /Latest-in-Cardiology/Articles/2026/05/19/15/49/JACC-Spotlight-Issue-2026-Dyslipidemia-Guideline A special JACC Spotlight Issue supporting the recently published 2026 ACC/AHA Guideline on the Management of Dyslipidemia, offers commentaries that provide a comprehensive overview of the new guideline recommendations and expert insights into understanding the science behind the recommendations... 1779206040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1777637340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1775045400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sat-345pm-vesaliuscv-acc-2026 The PCSK9 inhibitor evolocumab reduced the risk of a first major cardiovascular event in patients with diabetes without known significant atherosclerosis, according to a prespecified subgroup analysis of the VESALIUS-CV trial, presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in JAMA. 1774730760000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025 In this week’s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life. 1773842400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/03/13/15/20/ACC-AHA-Release-New-Clinical-Guideline-For-Managing-Dyslipidemia The new ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a) (Lp[a]). 1773415860000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/26/19/59/REVELUTION-More-Coronary-Plaque-Progression-With-Leuprolide-Than-Relugolix-in-Prostate-Cancer In men with localized prostate cancer (PCa) treated with radiation and androgen-deprivation therapy (ADT), treatment with the gonadotropin-releasing hormone (GnRH) leuprolide was associated with a significant 12-month increase in coronary artery plaque volume when compared with treatment with relugolix, according to a brief report of the REVELUTION trial published Feb. 18 in JAMA. 1772199900000 Articles and Stories /Latest-in-Cardiology/Articles/2026/02/19/11/58/Management-of-Dyslipidemia-in-People-Living-With-HIV Globally, an estimated 40.8 million people are living with HIV (PWH). Advances in antiretroviral therapy (ART) have enabled PWH to achieve a near-normal life expectancy; however, individuals taking ART remain at approximately twofold higher risk of developing atherosclerotic cardiovascular disease (ASCVD) ... 1771935660000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/17/14/32/No-Direct-Link A meta-analysis of individual patient data on all adverse events in large-scale, long-term trials of statin therapy found increases in hepatic transaminase and other liver function tests related to statin intensity, but found no evidence that statins cause the majority (62 of 66) of other adverse effects listed in statin labeling... 1771434420000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/01/01/Prioritizing-Health-hsCRP Inflammation plays a central role in the pathogenesis of atherosclerosis and cardiovascular disease. Atherosclerosis in particular is an inflammatory process that involves endothelial dysfunction, leukocyte adhesion, plaque formation and eventual rupture. 1764594600000 Articles and Stories